Abstract
Background: A significant number of patients depend on the intake of vitamin K antagonists for prevention and treatment of thromboembolic events. The development of portable anticoagulation monitors has enabled self-testing and self-adjustment of anticoagulation therapy.
Objective: To describe the principles of a training course to learn INR self-management and to illustrate reliability of our concept.
Description: The training is divided into an early postoperative training, an ambulatory training six months later, and a 24 hours care and consultation. According to our concept, each patient who depends on long-term anticoagulation therapy is able to learn INR self-management. Reliability of our concept has been proved in two prospective, randomized clinical trials.
Study results: A study with 1,155 patients has demonstrated that INR values lie more often in the predetermined target range in the INR self-management group if compared to the conventional group (79.2% vs. 64.9%; P < 0.001). Moreover, this study has demonstrated that self-management can lead to a reduction of thromboembolism (1.5% vs. 2.8%; P < 0.05), and to a lower lethality if compared to conventional INR management (3.5% vs 6.0%; P < 0.025). A second study with 1,816 patients has confirmed that INR self-management results in a high percentage of INR values in the target range (76%), even though target INR-range is reduced and narrowed. Thus, low dose INR self-management did not increase the risk of thromboembolism while avoiding the zone of higher risk for bleeding, beginning from INR > 3.5.
Conclusions: The Bad Oeynhausen concept of INR self-management is a promising tool to achieve low hemorrhagic complications without increasing the risk of thromboembolic complications. It can thus be successfully applied to patients with an indication for permanent anticoagulation therapy.
Similar content being viewed by others
References
Körtke H, Gohlke-Bärwolf C, Heik SCW, et al. Empfehlungen zum INR-Selbstmanagement bei oraler Antikoagulation. Z Kardiol 1998;87:983–985.
Machin SJ, Mackie IJ, Chitolie A, et al. Near patient testing (NPT) in haemostasis—a synoptic review. Clin Lab Haematol 1996;18:69–74.
Mühlhauser I, Berger M. Diabetes education and insulin therapy: When will they ever learn? J Intern Med 1993;233:321–326.
Sawicki PT, Mühlhauser I, Didjurgeit U, et al. Intensified antihypertensive therapy is associated with improved survival in type I diabetic patients with nephropathy. J Hypertens 1995;13:933–938.
White RH, McCurdy SA, von Marensdorff H, Woodruff DE, Leftgoff L. Home prothrobin time monitoring after the initiation of warfarin therapy. Ann Int Med 1989;111:730–737.
Sawicki P. A structured teaching and self-management program for patients receiving oral anticoagulation. JAMA 1999;281:145–150.
Cromheecke ME, Levi M, Colly LP, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: A randomize cross-over comparison. Lancet 2000;356:97–102.
Watzke HH, Forberg E, Svolba G, Jimenez-Boj E, Krinninger B. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost 2000;83:661–665.
Christensen TD, Andersen NT, Attermann J, Hjortdal VE, Maegaard M, Hasenkam JM. Mechanical heart valve patients can manage oral anticoagulant therapy themselves. Eur J Cardiothorac Surg 2003;23:292–298.
Schulman S. Care of patients receiving long-term anticoagulant therapy. New Engl J Med 2003;49:675–683.
Koertke H, Körfer R. International normalized ratio self-management after mechanical heart valve replacement: Is an early start advantageous? Ann Thorac Surg 2001;72:44–48.
Koertke H, Minami K, Boethig D, et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation 2003;108(suppl 1):II75–II78.
Oden A, Fahlen M. Oral anticoagulation and risk of death: A medical record linkage study. Br Med J 2002;325:1073–1075.
Morsdorf S, Erdlenbruch W, Taborski U, et al. Training of patients for self-management or oral anticoagulant therapy: Standards, patient suitability, and clinical aspects. Semin Thromb Hemost 1999;25:109–115.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koertke, H., Zittermann, A., Mommertz, S. et al. The Bad Oeynhausen Concept of INR Self-Management. J Thromb Thrombolysis 19, 25–31 (2005). https://doi.org/10.1007/s11239-005-0937-1
Issue Date:
DOI: https://doi.org/10.1007/s11239-005-0937-1